In this Issue
What Would You Do?
Chief Medical Editors’ Page
By Ted E. Feldman, MD, MSCAI, FACC, FESC; and Shakeel A. Qureshi, MD, FRCP, FRCPCH
Moderator: Mauricio G. Cohen, MD, FACC, FSCAI
Panel: Santiago Garcia, MD, FACC, FSCAI; William O’Neill, MD; and Molly Szerlip, MD, FACC, FSCAI
Moderator: Dee Dee Wang, MD, FACC, FASE, FSCCT
Panel: Mayra Guerrero, MD; and Marco Barbanti, MD
Moderator: Iqbal Malik, MD, FRCP, PhD
Panel: Soma Banerjee, MD(Res), FRCP; Andrew Chukwuemeka, MD, FRCS, FRCS(CTh); and Jonathan M. Tobis, MD, MSCAI
Moderator: William F. Fearon, MD
Panel: Morton J. Kern, MD, MSCAI, FAHA, FACC; Nils P. Johnson, MD, MS; and John McBarron Hodgson, MD, MSCAI
Moderator: Franz X. Kleber, MD
Panel: Finn Gustafsson, MD, PhD; and Felix Mahfoud, MD
Moderator: Pieter C. Smits, MD, PhD, FESC
Panel: Mohamed Abdel-Wahab, MD, FESC; Peter W. Danse, MD; and Valeria Paradies, MD
Moderator: Gianfranco Butera, MD, PhD, FSCAI
Panel: Henri Justino, MD, FRCPC; Raul Rossi, MD; and John Thomson, MD
Understanding the FDA device approval process and the difference between data from premarket and postapproval trials to make informed clinical decisions.
By Gary M. Ansel, MD; and Raghu Kolluri, MD, RVT, RPVI
CODING & REIMBURSEMENT
An overview of the steps involved in developing a PAD program to address this underserved patient population.
By Ginger Biesbrock, PA-C, MPH, MPAS, AACC; and Joel Sauer, MBA
Dr. Modine shares his thoughts on TAVI access approaches, evolving technology, and durability, as well as transcatheter mitral interventions and the expanding possibilities of valve-in-valve procedures.